Shares of Aurora Cannabis Inc. (NASDAQ:ACB – Get Free Report) fell 5.2% on Thursday . The stock traded as low as $4.33 and last traded at $4.42. 632,491 shares changed hands during mid-day trading, a decline of 28% from the average session volume of 875,832 shares. The stock had previously closed at $4.66.
Wall Street Analyst Weigh In
Several equities analysts have weighed in on the company. TD Securities upgraded Aurora Cannabis to a “strong-buy” rating in a report on Thursday, December 12th. TD Cowen started coverage on Aurora Cannabis in a report on Wednesday, December 11th. They issued a “buy” rating for the company.
Check Out Our Latest Research Report on ACB
Aurora Cannabis Stock Down 6.6 %
Institutional Investors Weigh In On Aurora Cannabis
A number of hedge funds have recently made changes to their positions in the company. Tidal Investments LLC boosted its stake in Aurora Cannabis by 2.7% in the third quarter. Tidal Investments LLC now owns 1,344,321 shares of the company’s stock worth $7,905,000 after purchasing an additional 34,988 shares in the last quarter. Headlands Technologies LLC lifted its position in shares of Aurora Cannabis by 98.8% during the second quarter. Headlands Technologies LLC now owns 74,988 shares of the company’s stock worth $346,000 after purchasing an additional 37,269 shares in the last quarter. TD Asset Management Inc acquired a new position in shares of Aurora Cannabis during the second quarter worth approximately $255,000. Mackenzie Financial Corp bought a new stake in shares of Aurora Cannabis during the second quarter valued at approximately $113,000. Finally, Toronto Dominion Bank increased its holdings in shares of Aurora Cannabis by 34,356.4% in the second quarter. Toronto Dominion Bank now owns 18,951 shares of the company’s stock valued at $88,000 after purchasing an additional 18,896 shares in the last quarter. Institutional investors and hedge funds own 47.63% of the company’s stock.
About Aurora Cannabis
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Featured Articles
- Five stocks we like better than Aurora Cannabis
- What Are Dividend Achievers? An Introduction
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- Insider Buying Explained: What Investors Need to Know
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- Stock Market Upgrades: What Are They?
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.